Literature DB >> 7512061

Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin.

D W Payne1, E D Williamson, H Havard, N Modi, J Brown.   

Abstract

A new cytotoxicity assay for determining the activity of epsilon toxin produced by Clostridium perfringens type D has been developed. Viability of cultured cells was determined by the ability of only live cells to convert 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4- sulfophenyl)tetrazolium to the coloured product formazan in the presence of phenazine methosulfate. Of the 12 cell lines tested, only the MDCK cell line was susceptible to epsilon toxin. Specificity was confirmed by the ability of only specific monoclonal antibodies to inhibit cytotoxicity. Good correlation was obtained with the mouse lethality assay (r = 0.991) and over a wide range of viability (15-75%) as determined by ethidium bromide/acridine orange staining (r = 0.995).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512061     DOI: 10.1111/j.1574-6968.1994.tb06695.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  19 in total

1.  Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery.

Authors:  R H Adamson; J C Ly; M Fernandez-Miyakawa; S Ochi; J Sakurai; F Uzal; F E Curry
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.

Authors:  Meredith L Hughes; Rachael Poon; Vicki Adams; Sameera Sayeed; Juliann Saputo; Francisco A Uzal; Bruce A McClane; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

3.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

5.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

6.  Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.

Authors:  L Petit; M Gibert; D Gillet; C Laurent-Winter; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

7.  Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen.

Authors:  Michelle Lewis; Charles David Weaver; Mark S McClain
Journal:  Toxins (Basel)       Date:  2010-07-01       Impact factor: 5.075

8.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

9.  Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin.

Authors:  Teal M Pelish; Mark S McClain
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

10.  Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.

Authors:  Monika Bokori-Brown; Maria C Kokkinidou; Christos G Savva; Sérgio Fernandes da Costa; Claire E Naylor; Ambrose R Cole; David S Moss; Ajit K Basak; Richard W Titball
Journal:  Protein Sci       Date:  2013-04-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.